Project Grant HT94252510943
- The federal Project Grant award of $749,049 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to Northeastern University for the project "ADVANCING OVERLOAD PREDICTION AND PROTECTION IN BONE-ANCHORED LIMBS". The award, with a performance period from June 1, 2025 to May 31, 2028, supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The...
- This $1,499,872 Project Grant was awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to Results Group, LLC, a small disadvantaged business specializing in advanced assistive technologies and rehabilitation devices. The grant supports the development of an exoskeleton-integrated boot system to facilitate longer-term rehabilitation and return to duty for military personnel recovering from lateral ankle sprains. The innovative solution...
- The Defense Health Agency awarded a $1,493,220 Project Grant to The Cleveland VA Medical Research & Education Foundation under the Military Medical Research and Development program (CFDA 12.420). The grant supports the development of a "Neurally Integrated Lower Limb Prosthesis for Home and Community Use" to aid mobility and sensory restoration for wounded veterans. The 4-year project, running from September 2023 to August 2027, aligns with the program's priorities of advancing...
- The University of South Florida has been awarded a $2,467,635 Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, titled "THE IM ABLE 2 STUDY: LONG TERM OUTCOMES TO ADVANCE CARE FOR WARRIORS AND VETERANS USING ADVANCED ANKLE FOOT ORTHOSES," will fund research to transform healthcare for military service members, veterans, and the broader public through the development of innovative medical solutions. The...
- The Defense Health Agency awarded a $2,635,000 Project Grant to Psyonic Inc., a minority-owned small disadvantaged business located in San Diego, California, to develop high-channel intramuscular and intrafascicular electrodes for transradial osseointegrated prostheses. This research is part of the Military Medical Research and Development program (CFDA 12.420), which supports advanced biomedical research to transform healthcare for military service members, veterans, and the broader public. The...
- The Defense Health Agency awarded The Trustees of Columbia University in the City of New York, doing business as Health Sciences Division, a $1,986,275 Project Grant under the Military Medical Research and Development program (CFDA 12.420). The grant supports the development of biofabricated, patient-specific skin gloves as a personalized therapy for mitten deformities in epidermolysis bullosa, a rare genetic skin disorder. The project will run from June 15, 2023 to June 14, 2027. The Military...
- The Defense Health Agency awarded a $3,995,791 project grant to Virginia Commonwealth University under the Military Medical Research and Development program (CFDA 12.420) to compare the attentional demands and functional outcomes of pattern recognition and direct myoelectric control in people with transradial amputation. VCU will conduct this research from September 2023 through September 2027 in Richmond, Virginia. Two subawards were also provided. Hanger Institute for Clinical Research and...
- The Defense Health Agency awarded a $487,765 Project Grant to The Johns Hopkins University under the Military Medical Research and Development program (CFDA 12.420) to develop "A NOVEL DIGITAL TWIN FOR OPTIMIZING NORMOTHERMIC VCA PRESERVATION". This 3-year research project, with a period of performance from September 30, 2025 to September 29, 2028, aims to advance biomedical research and innovation in healthcare solutions for military service members and the public. The Military...
- This $2,477,715.00 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program will support research conducted by the Regents of the University of Michigan to develop an exoskeleton control system using a muscle cuff regenerative peripheral nerve interface (MC-RPNI) for restoring lower limb function following traumatic musculoskeletal injury. The research aims to transform healthcare for military service members and the broader...
- The University of Arizona will receive $724,825 through September 2026 under a Project Grant from the Defense Health Agency. The grant supports the development of osseosurface electronics to monitor rehabilitation and accelerate return to duty following surgical treatment of long bone fractures. This award furthers the goals of the Military Medical Research and Development program (CFDA 12.420), which aims to transform military and public health care through innovative medical research solutions...
This $582,709 project grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to XO Armor Technologies, Inc., a small disadvantaged business in Auburn, Alabama, aims to conduct a comparative analysis of the effectiveness and compliance of autonomous computer-generated 3D printed wrist braces versus traditional bracing methods. The two-year grant, running from September 1, 2025 to August 31, 2027, represents a significant opportunity for XO Armor Technologies to contribute to medical research that could potentially transform healthcare solutions for military service members, veterans, and the broader public. The project leverages the company's expertise in 3D printing and advanced engineering to provide data-driven insights into more effective and compliant bracing methods.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $582.7k | 8/8/25 |